Corporate Performance
Corporate Performance Articles
Boeing rallies amid signals of confidence from a big hedge fund and a big aircraft leaser.
Published:
Lyft stock jumped this week after the ride-sharing company revised its outlook as riders slowly return.
Published:
Analysts foresee solid growth for Apple in the long term; the near term looks good too as the pandemic shutdown drives services demand.
Published:
Movie theater operator AMC Entertainment says that it may not be able to operate as a "going concern" because of the effects of the COVID-19 pandemic. What happens if all its screens go dark?
Published:
Nike doesn’t shy away from difficult subjects, and the current protest movement is no exception.
Published:
Mark Zuckerberg won’t remove or add warning labels to posts by President Trump, and that may be an issue for some advertisers, users and employees.
Published:
Snap reportedly is preparing to offer a stripped-down version of its platform that partners can embed in their own apps. Could this give the stock the shot in the arm that Wall Street is looking for?
Published:
Investors look at Aytu BioScience as it looks at expanding in the COVID testing field.
Published:
On Tuesday, AMD's chief financial officer laid out how the company plans to become cash-flow positive this year and generate a "significant amount of cash" over the next few years. Investors did not...
Published:
Shopify’s exponential growth has rewarded investors this year but Amazon is also powering ahead.
Published:
AT&T adapts its advertising to troubled times, spending more on live news and targeting stay-at-home consumers online.
Published:
Grubhub is reportedly seeking a breakup fee as regulators eye merger talks with Uber.
Published:
Although one major food producer was slapped by a European court this week, plenty of competitors are chasing the plant-based protein market. Beyond Meat is headed for China.
Published:
Aurora Cannabis closed its acquisition of Reliva ahead of schedule but poor results from Canopy Growth may have dinged pot stocks.
Published:
Amarin is going ahead with a big marketing campaign for potential COVID treatment Vascepa after a disruption caused by the pandemic.
Published: